These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 26629710)

  • 1. Reduction Responsive Self-Assembled Nanoparticles Based on Disulfide-Linked Drug-Drug Conjugate with High Drug Loading and Antitumor Efficacy.
    Song Q; Wang X; Wang Y; Liang Y; Zhou Y; Song X; He B; Zhang H; Dai W; Wang X; Zhang Q
    Mol Pharm; 2016 Jan; 13(1):190-201. PubMed ID: 26629710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox-responsive polymer-drug conjugates based on doxorubicin and chitosan oligosaccharide-g-stearic acid for cancer therapy.
    Su Y; Hu Y; Du Y; Huang X; He J; You J; Yuan H; Hu F
    Mol Pharm; 2015 Apr; 12(4):1193-202. PubMed ID: 25751168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin-Bound Hydroxyethyl Starch Conjugate Nanoparticles with pH/Redox Responsive Linkage for Enhancing Antitumor Therapy.
    Tan R; Tian D; Liu J; Wang C; Wan Y
    Int J Nanomedicine; 2021; 16():4527-4544. PubMed ID: 34276212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of linkers on the self-assembling and anti-tumor efficacy of disulfide-linked doxorubicin drug-drug conjugate nanoparticles.
    Wang Y; Wang X; Deng F; Zheng N; Liang Y; Zhang H; He B; Dai W; Wang X; Zhang Q
    J Control Release; 2018 Jun; 279():136-146. PubMed ID: 29655991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zwitterionic nanoparticles constructed from bioreducible RAFT-ROP double head agent for shell shedding triggered intracellular drug delivery.
    Huang P; Liu J; Wang W; Zhang Y; Zhao F; Kong D; Liu J; Dong A
    Acta Biomater; 2016 Aug; 40():263-272. PubMed ID: 26607767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A smart tumor targeting peptide-drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells.
    Song Q; Chuan X; Chen B; He B; Zhang H; Dai W; Wang X; Zhang Q
    Drug Deliv; 2016 Jun; 23(5):1734-46. PubMed ID: 25853477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of reduction-sensitive heterodimer prodrugs of doxorubicin and dihydroartemisinin self-assembled nanoparticles with antitumor activity.
    Ren G; Duan D; Wang G; Wang R; Li Y; Zuo H; Zhang Q; Zhang G; Zhao Y; Wang R; Zhang S
    Colloids Surf B Biointerfaces; 2022 Sep; 217():112614. PubMed ID: 35700564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glyco-nanoparticles with sheddable saccharide shells: a unique and potent platform for hepatoma-targeting delivery of anticancer drugs.
    Chen W; Zou Y; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
    Biomacromolecules; 2014 Mar; 15(3):900-7. PubMed ID: 24460130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
    Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
    Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
    Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
    Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
    [No Abstract]   [Full Text] [Related]  

  • 11. Amphiphilic peptide dendritic copolymer-doxorubicin nanoscale conjugate self-assembled to enzyme-responsive anti-cancer agent.
    Li N; Li N; Yi Q; Luo K; Guo C; Pan D; Gu Z
    Biomaterials; 2014 Nov; 35(35):9529-45. PubMed ID: 25145854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polylactide-graft-doxorubicin nanoparticles with precisely controlled drug loading for pH-triggered drug delivery.
    Yu Y; Chen CK; Law WC; Weinheimer E; Sengupta S; Prasad PN; Cheng C
    Biomacromolecules; 2014 Feb; 15(2):524-32. PubMed ID: 24446700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitooligosaccharides Modified Reduction-Sensitive Liposomes: Enhanced Cytoplasmic Drug Delivery and Osteosarcomas-Tumor Inhibition in Animal Models.
    Yin X; Chi Y; Guo C; Feng S; Liu J; Sun K; Wu Z
    Pharm Res; 2017 Oct; 34(10):2172-2184. PubMed ID: 28726003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
    Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
    Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH and redox dual-sensitive polysaccharide nanoparticles for the efficient delivery of doxorubicin.
    Yang S; Tang Z; Zhang D; Deng M; Chen X
    Biomater Sci; 2017 Sep; 5(10):2169-2178. PubMed ID: 28914292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galactose-Containing Polymer-DOX Conjugates for Targeting Drug Delivery.
    Sun Y; Zhang J; Han J; Tian B; Shi Y; Ding Y; Wang L; Han J
    AAPS PharmSciTech; 2017 Apr; 18(3):749-758. PubMed ID: 27287244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery.
    Thambi T; You DG; Han HS; Deepagan VG; Jeon SM; Suh YD; Choi KY; Kim K; Kwon IC; Yi GR; Lee JY; Lee DS; Park JH
    Adv Healthc Mater; 2014 Nov; 3(11):1829-38. PubMed ID: 24753360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charge-conversional PEG-polypeptide polyionic complex nanoparticles from simple blending of a pair of oppositely charged block copolymers as an intelligent vehicle for efficient antitumor drug delivery.
    Lv S; Song W; Tang Z; Li M; Yu H; Hong H; Chen X
    Mol Pharm; 2014 May; 11(5):1562-74. PubMed ID: 24606535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
    Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S
    Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect.
    Xie Q; Deng W; Yuan X; Wang H; Ma Z; Wu B; Zhang X
    Eur J Pharm Biopharm; 2018 Jan; 122():87-95. PubMed ID: 29032193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.